| Financial Year |
March 31 2023 |
| Monetary Funds |
5,916,332,513.09 |
| Held-for-trading Financial Assets |
1,261,500,945.36 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,710,426,510.48 |
| Advances to Suppliers |
684,264,167.56 |
| Other Receivables |
78,834,001.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,108,210,988.98 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
409,340,231.23 |
| Total Current Assets |
12,168,909,358.04 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
214,180,211.54 |
| Long-term Equity Investment |
29,889,158,613.59 |
| Investment Properties |
68,791,684.91 |
| Fixed Assetes |
3,004,580,154.47 |
| Under-construction Projects |
461,555,615.98 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
721,681,297.07 |
| R&D expenses |
235,130,586.00 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
23,687,611.58 |
| Deferred Income Tax Assets |
52,628,098.68 |
| Other Non-Current Assets |
311,640,717.73 |
| Sub-Total of Non-Current Assets |
35,314,467,975.85 |
| Total Assets |
47,483,377,333.89 |
| Short-Term Loans |
6,777,115,066.26 |
| Trading Financial liabilities |
-- |
| Notes Payable |
203,770,524.15 |
| Accounts Payable |
485,490,658.05 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
71,781,082.79 |
| Taxes Payable |
52,575,773.51 |
| Interest Payable |
-- |
| Dividend Payable |
149,700.00 |
| Other payables |
73,507,785.10 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
208,004,435.02 |
| Other Current Liabilities |
2,135,406,113.99 |
| Sub-Total of Current Liabilities |
10,078,995,770.54 |
| Long-term Loans |
967,000,000.00 |
| Bonds Payable |
3,486,746,806.09 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
216,502,461.66 |
| Deferred Income Tax Liabilities |
21,538,269.42 |
| Other Non-Current Liabilities |
3,154.00 |
| Sub-Total of Non-Current Liabilities |
4,846,383,478.08 |
| Total Liabilities |
14,925,379,248.62 |
| Paid-In Capital(Or Share Stock) |
1,529,709,816.00 |
| Capital Surplus |
8,379,926,290.03 |
| Surplus Reserve |
824,360,081.93 |
| LESS:Treasury Stock |
69,873,386.94 |
| Undistributed Profits |
18,173,690,698.95 |
| Minority Stockholder's Interest |
3,522,328,208.15 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
29,035,669,877.12 |
| Owner's Equity（Stockholder's Equity） |
32,557,998,085.27 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
47,483,377,333.89 |
